MYLAN 7096 MYLAN 7096
Pill imprint MYLAN 7096 MYLAN 7096 has been identified as Bromocriptine mesylate 5 mg.
Bromocriptine is used in the treatment of hyperprolactinemia; diabetes, type 2; parkinson's disease; acromegaly; tardive dyskinesia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy.
Bromocriptine 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Bromocriptine mesylate Images
- Imprint:
-
MYLAN 7096
MYLAN 7096 - Strength:
- 5 mg
- Color:
- Brown & White
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
Prolactin inhibitors - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-7096
- Inactive Ingredients:
- lactose anhydrous
ferric oxide black
D&C Yellow No. 10 Aluminium Lake
FD&C Blue No. 1 Aluminium Lake
FD&C Blue No. 2 Aluminium Lake
FD&C Red No. 40 Aluminium Lake
gelatin
magnesium stearate
maleic acid
butyl alcohol
pregelatinized starch
propylene glycol
ferric oxide red
sda-3a alcohol
sd-45 alcohol
shellac
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68258-9144 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Bromocriptine Mesylate resources
- Bromocriptine (Wolters Kluwer)
- Bromocriptine Mesylate (Wolters Kluwer)
- bromocriptine (Cerner Multum)
- bromocriptine (Micromedex) - Includes Dosage Information
- Bromocriptine Mesylate (AHFS DI)
- Bromocriptine (FDA)
- Bromocriptine Capsules (FDA)
- Bromocriptine Mesylate (Wolters Kluwer)
Search Again
